Peapod Lane Capital’s Kezar Life Sciences KZR Stock Holding History

Peapod Lane Capital’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-126,692	Closed	-$925K	–	66
2026 Q1	$925K	Sell	126,692 -7	-0%	-$46	0.76%	52
2025 Q4	$797K	Buy	126,699 +926	+0.7%	+$5.4K	0.68%	52
2025 Q3	$491K	Buy	125,773 +10,650	+9%	+$43.7K	0.44%	56
2025 Q2	$527K	Sell	115,123 -9,304	-7%	-$39.9K	0.53%	53
2025 Q1	$607K	Buy	124,427 +433	+0.3%	+$2.63K	0.68%	50
2024 Q4	$833K	Buy	+123,994	New	+$924K	0.83%	47

Peapod Lane Capital's KZR Position: Q2 2026 in Review

Peapod Lane Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 126,692 shares — an estimated $925K sold.

Peapod Lane Capital first reported a position in KZR in Q4 2024 and held it in 6 quarters. The position peaked at $925K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Peapod Lane Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Peapod Lane Capital sold 126,692 Kezar Life Sciences shares in Q2 2026, an estimated $925K.
Peapod Lane Capital first reported a position in Kezar Life Sciences in Q4 2024 and held it in 6 quarters.
Peapod Lane Capital's Kezar Life Sciences position peaked at $925K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.